Tony Liu, from Dallas, Texas, is pursuing a PhD in bioengineering at Stanford School of Engineering. He graduated from Yale University with a bachelor's of science in physics. Tony cares about supporting those facing severe neuropsychiatric conditions in pursuing meaningful, self-determined lives. To that end, he aspires to develop treatments which target precisely localized brain circuits at the optimal times to repair dysfunction. In labs at Yale, Tony helped develop protein tools that glow when brain cells are active, and applied those tools to understanding computation in small brain circuits. He has interned on the healthcare+AI research team of a Chinese venture capital firm, and, at the University of California, San Francisco, performed biomarker discovery on the clinical trial team developing the first closed-loop neuromodulation therapy for treatment-resistant depression. He served as a public psychiatry fellow at the Connecticut Mental Health Center and is a recipient of the Goldwater Scholarship.